Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Acute coronary syndromes without persistent ST-segment elevation: is risk stratification correctly applied?].

Marcello Galvani1, Filippo Ottani, Donatella Ferrini

  • 1UO di Cardiologia, Ospedale G.B. Morgagni, Forlì. galvanim@tin.it

Italian Heart Journal : Official Journal of the Italian Federation of Cardiology
|June 11, 2005
PubMed
Summary

Accurate risk stratification for acute coronary syndromes is crucial. Current guidelines may over-identify high-risk patients, potentially straining resources, yet a more aggressive approach is emerging for neglected subgroups.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Percutaneous management of delayed aortic annular rupture after transcatheter aortic valve implantation complicated by severe aortic regurgitation.

The Journal of invasive cardiology·2026
Same author

Early multimodal predictors of good neurological outcome in comatose patients after cardiac arrest: a prospective single-center cohort study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Preliminary Outcome of Transcatheter Aortic Valve Implantation at Centers Without On-Site Cardiac Surgery.

Journal of cardiovascular development and disease·2026
Same author

Standard modifiable cardiovascular risk factors and acute coronary syndrome free survival.

Atherosclerosis·2026
Same author

Beta-blockers after invasively managed STEMI vs NSTEMI without reduced ejection fraction: a prespecified analysis from the REBOOT trial.

Revista espanola de cardiologia (English ed.)·2026
Same author

[The paradigm shift for beta-blockers after myocardial infarction. Lessons learned from the REBOOT and BETAMI-DANBLOCK trials].

Giornale italiano di cardiologia (2006)·2026

Area of Science:

  • Cardiology
  • Clinical Risk Stratification
  • Acute Coronary Syndromes

Context:

  • Effective risk stratification for acute coronary syndromes (ACS) is vital for optimal treatment and resource allocation.
  • Current European Society of Cardiology guidelines recommend a univariate approach for ACS risk assessment, prioritizing sensitivity over specificity.
  • This approach may lead to over-identification of high-risk patients, causing a potential mismatch with available interventional resources.

Purpose:

  • To evaluate the accuracy of current risk stratification methods for acute coronary syndromes.
  • To analyze the implications of guideline-recommended univariate risk assessment in ACS patient management.
  • To identify key prognostic indicators and high-risk subgroups within ACS patients.

Summary:

Related Experiment Videos

  • Key indicators for adverse cardiac events in ACS include heart failure, ST-segment shifts on ECG, and elevated myocardial damage markers.
  • Additional risk factors like diabetes, renal insufficiency, advanced age, and prior revascularization further elevate risk.
  • Italian regional registries indicate a positive trend towards more aggressive management of these previously neglected high-risk ACS subgroups.

Impact:

  • Improved accuracy in risk stratification can lead to better patient outcomes and more efficient allocation of healthcare resources.
  • Addressing the undertreatment of high-risk ACS patients, particularly those with comorbidities, is essential.
  • The findings support a shift towards more tailored and aggressive therapeutic strategies for specific high-risk ACS populations.